Clinical Trial Update: Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial examining repurposed Probenecid as a positive inotrope for systolic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systolic Heart Failure

Drugs mentioned

• Probenecid (probenecid)

Snippet

Sponsor: University of Cincinnati | Conditions: Systolic Heart Failure | Phase 2 | Status: COMPLETED